Literature DB >> 20215960

Managing financial and nonfinancial conflicts of interest in healthcare delivery.

Aaron S Kesselheim1, William H Maisel.   

Abstract

The issue of conflicts of interest held by physicians and other caregivers has drawn increased attention in recent years. In response, some commentators and institutions have proposed policies intended to protect patients' rights, including disclosure of relationships with for-profit companies. Conflicts of interest policies must balance the need for transparency and patient safety, but must also take into account the positive aspects of such relationships, including innovative product development. This article discusses various types of conflicts that can and do occur in healthcare delivery and potential policy options that may address these issues. The case history, device, physician, and patient described below do not represent actual people or events, but are intended to be emblematic of the challenges faced in the current medical marketplace.

Entities:  

Mesh:

Year:  2010        PMID: 20215960     DOI: 10.1097/MJT.0b013e3181d01cae

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


  3 in total

1.  "Members of the same club": challenges and decisions faced by US IRBs in identifying and managing conflicts of interest.

Authors:  Robert Klitzman
Journal:  PLoS One       Date:  2011-07-29       Impact factor: 3.240

2.  Joint issues--conflicts of interest, the ASR hip and suggestions for managing surgical conflicts of interest.

Authors:  Jane Johnson; Wendy Rogers
Journal:  BMC Med Ethics       Date:  2014-08-15       Impact factor: 2.652

3.  "We can't get along without each other": Qualitative interviews with physicians about device industry representatives, conflict of interest and patient safety.

Authors:  Anna R Gagliardi; Pascale Lehoux; Ariel Ducey; Anthony Easty; Sue Ross; Chaim Bell; Patricia Trbovich; David R Urbach
Journal:  PLoS One       Date:  2017-03-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.